Jiangsu Hengrui Medicine Co., Ltd. (HKG:1276)
Hong Kong · Delayed Price · Currency is HKD 86.20
0.00 (0.00%)
At close: Sep 8, 2025
Jiangsu Hengrui Medicine Market Cap
Jiangsu Hengrui Medicine has a market cap or net worth of 526.09 billion as of September 8, 2025. Its market cap has increased by 74.64% in one year.
Market Cap
526.09B
Enterprise Value
487.21B
Revenue
33.03B
Ranking
n/a
PE Ratio
65.28
Stock Price
86.20
Market Cap Chart
Since October 20, 2000, Jiangsu Hengrui Medicine's market cap has increased from 2.43B to 526.09B, an increase of 21,575.98%. That is a compound annual growth rate of 24.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2025 | 526.09B | 69.39% |
| Dec 31, 2024 | 310.59B | -1.97% |
| Dec 29, 2023 | 316.84B | 14.05% |
| Dec 30, 2022 | 277.81B | -29.95% |
| Dec 31, 2021 | 396.57B | -43.57% |
| Dec 31, 2020 | 702.75B | 62.99% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 293.19B |
| Hansoh Pharmaceutical Group Company | 224.72B |
| JD Health International | 204.41B |
| Innovent Biologics | 176.58B |
| Sino Biopharmaceutical | 159.35B |
| WuXi Biologics | 150.75B |
| Akeso | 142.50B |
| CSPC Pharmaceutical Group | 127.94B |